This site is intended for healthcare professionals only
LoginRegister
GSK Nucala application for COPD accepted for review in ChinaWHO prequalifies GSK malaria vaccine Mosquirix
Pfizer secures USFDA Breakthrough Therapy designation for Group B Streptococcus VaccinePfizer secures USFDA Breakthrough Therapy designation for Group B Streptococcus Vaccine
Pfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for 12 years and olderPfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine...
CDSCO panel recommends Biological E 14-valent paediatric vaccine against S pneumoniaCDSCO panel recommends Biological E 14-valent paediatric vaccine against S pneumonia
Improving effects of protein-based COVID-19 vaccinesImproving effects of protein-based COVID-19 vaccines
BCG vaccine provides protection from TB to young children, not adolescents or adults: LancetBCG vaccine provides protection from TB to young children, not adolescents or adults: Lancet
Universal flu vaccine for influenza A and B virus variantsUniversal flu vaccine for influenza A and B virus variants
COVID vaccine 73.2 percent effective in children under 5: PfizerCOVID vaccine 73.2 percent effective in children under 5: Pfizer
Bharat Biotech rotavirus oral vaccine ROTAVAC introduced in Nigeria for childrenBharat Biotech rotavirus oral vaccine ROTAVAC introduced in Nigeria for children
Moderna seeks USFDA nod for COVID booster tailored against Omicron subvariantsModerna seeks USFDA nod for COVID booster tailored against Omicron subvariants
Risk of myocarditis significantly lower after vaccination than after COVID 19 infectionRisk of myocarditis significantly lower after vaccination than after COVID 19 infection
Pfizer, BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of age and olderPfizer, BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of...
X